Dermatology Doctors in Henrico, VA Accepting Medicare

6 Dermatology doctors found. Showing 1 - 6

Dr. Shelley Kae Hoover, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7813 Shrader Rd, Henrico, VA 23294 Phone: 804-264-4262    Fax: 804-264-4260

Thao Tran, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7813 Shrader Rd, Henrico, VA 23294 Phone: 804-264-4545    Fax: 804-264-4545

Dr. Donna Marie Hepper, M.D. Dermatology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 7813 Shrader Rd, Henrico, VA 23294 Phone: 804-264-4545

Dr. Nancy H Thornton, Dermatology Medicare: Not Enrolled in Medicare Practice Location: 7813 Shrader Rd, Henrico, VA 23294 Phone: 804-264-4262    Fax: 804-264-4260

Diem N Wu, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7813 Shrader Rd, Henrico, VA 23294 Phone: 804-264-4545    Fax: 804-264-4545

Dr. Christine S Rausch, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2510 Gaskins Road, Henrico, VA 23238 Phone: 804-282-4940    Fax: 804-282-4941

News Archive

Cangene Corporation announces financial results for the fiscal year ended July 31, 2009

Cangene Corporation today reports financial results for the fiscal year ended July 31, 2009.

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

Gateway Foundation to raise awareness of synthetic drug use

In recognition of Red Ribbon Week, October 23-31, 2012, Gateway Foundation Alcohol & Drug Treatment is working to build awareness among communities regarding the dangerous health risks associated with synthetic drug use.

Treating aged mice with natural product appears to have positive effects on health and lifespan

Previous research published earlier this year in Nature Medicine involving University of Minnesota Medical School faculty Paul D. Robbins and Laura J. Niedernhofer and Mayo Clinic investigators James L. Kirkland and Tamara Tchkonia, showed it was possible to reduce the burden of damaged cells, termed senescent cells, and extend lifespan and improve health, even when treatment was initiated late in life.

Inadequate payments prompt insurance companies to raise premiums, avoid low-income market

Millions of Medicare recipients have been forcibly reassigned to different prescription drug plans because Part D reimbursements to insurance companies covering low-income patients are lower than the actual costs incurred, according to a study released online today by Health Affairs. The report describes how a system designed to encourage competition and to subsidize care for low-income Medicare patients instead has led companies to raise their premiums in an effort to price themselves out of the low-income segment of the Part D market.

Read more Medical News

› Verified 8 days ago